275 related articles for article (PubMed ID: 33568368)
21. Prophylactic Melatonin for Delirium in Intensive Care (Pro-MEDIC): study protocol for a randomised controlled trial.
Martinez FE; Anstey M; Ford A; Roberts B; Hardie M; Palmer R; Choo L; Hillman D; Hensley M; Kelty E; Murray K; Singh B; Wibrow B
Trials; 2017 Jan; 18(1):4. PubMed ID: 28061873
[TBL] [Abstract][Full Text] [Related]
22. Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction.
Palmer KR; Mockler JC; Davies-Tuck ML; Miller SL; Goergen SK; Fahey MC; Anderson PJ; Groom KM; Wallace EM
BMJ Open; 2019 Jun; 9(6):e028243. PubMed ID: 31230020
[TBL] [Abstract][Full Text] [Related]
23. Double-blind, randomised placebo-controlled clinical trial of metformin as an adjunct to a sleep-wake, activity and metabolically focused behavioural intervention to improve cardiometabolic outcomes and mood symptoms in youth with major mood syndromes: study protocol.
Wilson C; Carpenter JS; Nichles A; Zmicerevska N; Song YJC; McHugh C; Hamilton B; Hockey S; Crouse J; Koethe D; Scott EM; Hickie IB
BMJ Open; 2023 Feb; 13(2):e064682. PubMed ID: 36810174
[TBL] [Abstract][Full Text] [Related]
24. The preventative role of exogenous melatonin administration to patients with advanced cancer who are at risk of delirium: study protocol for a randomized controlled trial.
Bush SH; Lacaze-Masmonteil N; McNamara-Kilian MT; MacDonald AR; Tierney S; Momoli F; Agar M; Currow DC; Lawlor PG
Trials; 2016 Aug; 17():399. PubMed ID: 27515515
[TBL] [Abstract][Full Text] [Related]
25. Study protocol for the BRAIN Training Trial: a randomised controlled trial of Balance, Resistance, And INterval training on cognitive function in older adults with mild cognitive impairment.
Valenzuela T; Coombes JS; Liu-Ambrose T; Mavros Y; Kochan N; Sachdev PS; Hausdorff J; Smith EC; Hollings M; Hawkins TC; Ashley NJ; Feter N; Wilson GC; Shih IHE; Guerrero Y; Jiang J; Wen W; Bailey T; Stensvold D; Wisløff U; Falck RS; Fiatarone Singh M
BMJ Open; 2022 Dec; 12(12):e062059. PubMed ID: 36600421
[TBL] [Abstract][Full Text] [Related]
26. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
27. A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial.
Possemis N; Verhey F; Prickaerts J; Blokland A; Ramakers I
Trials; 2024 Mar; 25(1):162. PubMed ID: 38438923
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of a 6-month pilot randomised controlled trial of resistance training on cognition and brain health in Canadian older adults at-risk for diabetes: study protocol.
Furlano JA; Nagamatsu LS
BMJ Open; 2019 Oct; 9(10):e032047. PubMed ID: 31585978
[TBL] [Abstract][Full Text] [Related]
29. Phase II, double blind, placebo controlled, multi-site study to evaluate the safety, feasibility and desirability of conducting a phase III study of anamorelin for anorexia in people with small cell lung cancer: A study protocol (LUANA trial).
Sousa MS; Martin P; Johnson MJ; Lind M; Maddocks M; Bullock A; Agar M; Chang S; Kochovska S; Kinchin I; Morgan D; Fazekas B; Razmovski-Naumovski V; Lee JT; Itchins M; Bray V; Currow DC
PLoS One; 2023; 18(5):e0285850. PubMed ID: 37195996
[TBL] [Abstract][Full Text] [Related]
30. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Sharpley AL
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
[TBL] [Abstract][Full Text] [Related]
31. PRECISE trial (Pain RElief Combination Intervention StratEgies): protocol for the clinical trial of a pregabalin-melatonin combination for fibromyalgia.
Gilron I; DeBow C; Elkerdawy H; Khan JS; Salomons TV; Duggan S; Tu D; Holden RR; Milev R; Buckley DN; Moulin DE
BMJ Open; 2024 Jun; 14(6):e087180. PubMed ID: 38910006
[TBL] [Abstract][Full Text] [Related]
32. A Series of Remote Melatonin Supplement Interventions for Poor Sleep: Protocol for a Feasibility Pilot Study for a Series of Personalized (N-of-1) Trials.
Butler M; D'Angelo S; Perrin A; Rodillas J; Miller D; Arader L; Chandereng T; Cheung YK; Shechter A; Davidson KW
JMIR Res Protoc; 2023 Aug; 12():e45313. PubMed ID: 37535419
[TBL] [Abstract][Full Text] [Related]
33. MyCOACH (COnnected Advice for Cognitive Health): a digitally delivered multidomain intervention for cognitive decline and risk of dementia in adults with mild cognitive impairment or subjective cognitive decline-study protocol for a randomised controlled trial.
Amos JG; Zheng L; Eramudugolla R; Parekh D; Huque MH; Delbaere K; Lautenschlager N; Anstey KJ
BMJ Open; 2023 Oct; 13(10):e075015. PubMed ID: 37903606
[TBL] [Abstract][Full Text] [Related]
34. The Australian Research Council Longevity Intervention (ARCLI) study protocol (ANZCTR12611000487910) addendum: neuroimaging and gut microbiota protocol.
Simpson T; Deleuil S; Echeverria N; Komanduri M; Macpherson H; Suo C; Gondalia S; Fard MT; Pipingas A; Scholey A; Stough C
Nutr J; 2019 Jan; 18(1):1. PubMed ID: 30611275
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial.
Sha Z; Zhao Z; Li N; Xiao S; Li O; Zhang J; Li Z; Xu J
BMC Complement Med Ther; 2023 Apr; 23(1):101. PubMed ID: 37013520
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of a supplement combination for hand osteoarthritis pain: protocol for an internet-based randomised placebo-controlled trial (The RADIANT study).
Liu X; Robbins S; Eyles J; Fedorova T; Virk S; Deveza LA; McLachlan A; Hunter D
BMJ Open; 2020 Feb; 10(2):e035672. PubMed ID: 32075845
[TBL] [Abstract][Full Text] [Related]
37. Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer.
Bean HR; Stafford L; Little R; Diggens J; Ftanou M; Alexander M; Francis PA; Bei B; Wiley JF
Trials; 2020 Mar; 21(1):295. PubMed ID: 32216832
[TBL] [Abstract][Full Text] [Related]
38. Protocol for SYNchronising Exercises, Remedies in GaIt and Cognition at Home (SYNERGIC@Home): feasibility of a home-based double-blind randomised controlled trial to improve gait and cognition in individuals at risk for dementia.
McGibbon C; Jarrett P; Handrigan G; Bouchard D; Tranchant CC; Sexton AM; Yetman L; Robinson B; Crapoulet S; Chamard-Witkowski L; Liu-Ambrose T; Middleton LE; Almeida QJ; Bherer L; Lim A; Speechley M; Kamkar N; Montero Odasso M;
BMJ Open; 2022 Mar; 12(3):e059988. PubMed ID: 35361653
[TBL] [Abstract][Full Text] [Related]
39. Melatonin for sleep disorders in children with neurodevelopmental disorders: protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials.
Jørgensen CK; Hermann R; Juul S; Faltermeier P; Horowitz M; Moncrieff J; Gluud C; Jakobsen JC
BMJ Open; 2022 Nov; 12(11):e065520. PubMed ID: 36446459
[TBL] [Abstract][Full Text] [Related]
40. Occupational therapist-led mindfulness-based stress reduction for older adults living with subjective cognitive decline or mild cognitive impairment in primary care: a feasibility randomised control trial protocol.
Tran T; Donnelly C; Nalder EJ; Trothen T; Finlayson M
BMJ Open; 2020 Jun; 10(6):e035299. PubMed ID: 32580984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
